Current participation in another study where the total volume of blood drawn, when added to this study blood draw volume, exceeds 500cc in an 8 week period
Any medical issue or pharmacologic exposure which, in the opinion of the study investigator, that might interfere with the study objectives
Any reason which, in the opinion of the study investigator, adds additional risk to the participant
Clareo Health | Tracing Of Real-time glu13Cose Metabolism in Human Immune Cells
